IP Library › Patent Application 16549961
Patent Application
App. No. 16/549,961

USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/549,961
Abstract

Provided herein are methods for identifying a subject with cancer for treatment with a Psap peptides. The subject is identified based on a level of CD36. Also provided herein are compositions and methods for treatment of a subject with cancer based on a level of CD36.

Claims (3)

1 . A method for evaluating a subject' s responsiveness to treatment ith a Psap peptide, the method comprising:

determining a level of CD36 in a sample obtained from a subject having cancer, wherein an elevated level of CD36 in the sample compared to a control level indicates that the subject is responsive to or likely to be responsive to treatment with a Psap peptide.

2 - 33 . (canceled)

Assignments (3)
LICENSE Recorded Dec 18, 2024
From: BOSTON CHILDREN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 069719/0502 →
CONFIRMATORY LICENSE Recorded Aug 15, 2023
From: BOSTON CHILDREN'S HOSPITAL
To: NIH-DEITR
Reel/Frame 064598/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2022
From: WATNICK, RANDOLPH S.
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 059521/0718 →